Animal model of sclerotic skin induced by bleomycin: A clue to the pathogenesis of and therapy for scleroderma?

被引：25
|
作者：
Yamamoto, T [1 ]
机构：
[1] Tokyo Med & Dent Univ, Sch Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138519, Japan
来源：
CLINICAL IMMUNOLOGY | 2002年 / 102卷 / 03期
关键词：
D O I：
10.1006/clim.2001.5169
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
[No abstract available]
引用
收藏
页码：209 / 216
页数：8
相关论文
共 50 条
  • [41] Antioxidant Effect of Epigallocatechin-3-Gallate in a Bleomycin-Induced Scleroderma Model
    Kocak, Ayse
    Harmanci, Duygu
    Cavdar, Zahide
    Ural, Cemre
    Birlik, Merih
    Sarioglu, Sulen
    Yilmaz, Osman
    Guner Akdogan, Gul
    ARCHIVES OF RHEUMATOLOGY, 2019, 34 (01) : 1 - 8
  • [42] CHROMOSOMAL ABERRATIONS ARE ASSOCIATED WITH DISEASE SEVERITY IN A MOUSE MODEL OF BLEOMYCIN-INDUCED SCLERODERMA
    Luisetto, R.
    Beggio, M.
    Scanu, A.
    de Oliveira, F. Leite
    Pigatto, E.
    Peruffo, A.
    Zanatta, E.
    Oliviero, F.
    Sfriso, P.
    Punzi, L.
    Cozzi, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1111 - 1111
  • [43] Altered Expression of Neuropeptide Receptors in the Bleomycin (Bleo)-Induced Mouse Model of Scleroderma (SSc)
    Parra, James, II
    Ibrahim, Mohamed
    McKinnon, Elizabeth
    Levinson, Howard
    Sunday, Mary E.
    FASEB JOURNAL, 2017, 31
  • [44] Effect of Ac-SDKP, ramipril, and spironolactone on skin fibrosis in murine bleomycin-induced scleroderma
    Desai, S.
    Carretero, O. A.
    Rhaleb, N.
    Peng, H.
    Lim, H. W.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2007, 127 : S32 - S32
  • [45] Nimbolide ameliorates fibrosis and inflammation in experimental murine model of bleomycin-induced scleroderma
    Snehalatha Diddi
    Swarna Bale
    Gauthami Pulivendala
    Chandraiah Godugu
    Inflammopharmacology, 2019, 27 : 139 - 149
  • [46] CCN1 EXPRESSION BY FIBROBLASTS HAS A ROLE IN BLEOMYCIN INDUCED SKIN FIBROSIS AND IS A POTENTIAL TARGET FOR ANTI-FIBROTIC THERAPY IN SCLERODERMA
    Quensel, K.
    Hutchenreuther, J.
    Xu, S.
    Hinz, B.
    Siqueira, W.
    O'Gorman, D.
    Stratton, R.
    Leask, A.
    WOUND REPAIR AND REGENERATION, 2020, 28 (02) : A12 - A12
  • [47] Pyroptosis executor gasdermin D plays a key role in scleroderma and bleomycin-induced skin fibrosis
    Huan Yang
    Yanqiang Shi
    Huiting Liu
    Feiyan Lin
    Biying Qiu
    Qinglan Feng
    Yu Wang
    Bin Yang
    Cell Death Discovery, 8
  • [48] Scleroderma-like skin changes induced by checkpoint inhibitor therapy
    Tjarks, B. Joel
    Kerkvliet, Amy M.
    Jassim, Ali D.
    Bleeker, Jonathan S.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2018, 45 (08) : 615 - 618
  • [49] Pharmacological inhibition of leukotrienes in an animal model of bleomycin induced lung fibrosis
    Vancheri, C.
    Failla, M.
    Genovese, T.
    Mazzon, E.
    Gili, E.
    Muia, C.
    Sortino, M.
    Caputi, A. P.
    Cuzzocrea, S.
    Crimi, N.
    SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2006, 23 (02) : 146 - 146
  • [50] CD19 regulates skin and lung fibrosis via toll-like receptor signaling in a model of bleomycin-induced scleroderma
    Yoshizaki, Ayumi
    Iwata, Yohei
    Komura, Kazuhiro
    Ogawa, Fumihide
    Hara, Toshihide
    Muroi, Eiji
    Takenaka, Motoi
    Shimizu, Kazuhiro
    Hasegawa, Minoru
    Fujimoto, Manabu
    Tedder, Thomas F.
    Sato, Shinichi
    AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (06): : 1650 - 1663
12345